Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Endologix has received Shonin approval from the Japanese Ministry of Health, Labour and Welfare and the company will soon be initiating Powerlink System product shipments to Japan.
Subscribe to our email newsletter
Endologix’s Powerlink System is an endoluminal stent graft for treating abdominal aortic aneurysms.
Paul McCormick, president and CEO of Endologix, said: “We will begin by shipping an initial stocking order in February to our Japanese distributor Cosmotec and expect that the first Powerlink System implants will be performed at the Tokyo Medical University Hospital.”